Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma

Clinical trial NCT00901069 · COMPLETED

Trial details

NCT number: NCT00901069
Sponsor: Shams Shakil
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Hodgkin Disease Lymphoma, Non-Hodgkin

Start date: 2009-05-01
Primary completion: 2012-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.